Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $70.11 Analyst target: $77.50 Upside: 10.54%
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.
See the full interactive analysis & chart →Informational only — not investment advice.